Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04071392 · ClinicalTrials.gov registry record
Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 24
- Enrollment target
NCT04071392: Completed study, sponsored by Oregon Health and Science University.
NCT04071392 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04071392 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The overarching goal of this study is to find an alternative method to hysterosalpingogram (HSG) to confirm bilateral tubal occlusion after permanent contraception.
Primary Outcome
After placement of the hysterosalpingogram catheter, investigators use an infusion pump to deliver normal saline under continuous pressure monitoring until reaching one of the following endpoints: delivery of the entire volume of 10mL (milliliter); a peak pressure of 450mmHg (millimeters of Mercury); or the participant requested the infusion to stop due to intolerable discomfort. After one minute, investigators withdraw the delivered fluid through the hysterosalpingogram catheter and record the
Interventions
- PROCEDURE Hysterosalpingogram (HSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-07-31 |
What the finished NCT04071392 record still lists
NCT04071392 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Hysterosalpingogram (HSG) is the first listed.
NCT04071392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04071392 about?
NCT04071392 is a clinical study titled "Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion". The overarching goal of this study is to find an alternative method to hysterosalpingogram (HSG) to confirm bilateral tubal occlusion after permanent contraception.
What is the current status of trial NCT04071392?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2016-09-01. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT04071392?
The interventions under investigation include: Hysterosalpingogram (HSG) (PROCEDURE).
Who is sponsoring clinical trial NCT04071392?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI